Annual Total Long Term Liabilities
$686.00 K
-$3.51 M-83.64%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual total long term liabilities is $686.00 thousand, with the most recent change of -$3.51 million (-83.64%) on December 31, 2023.
- During the last 3 years, ENLV annual total long term liabilities has risen by +$187.00 thousand (+37.47%).
- ENLV annual total long term liabilities is now -87.27% below its all-time high of $5.39 million, reached on December 31, 2021.
Performance
ENLV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$419.00 K
-$80.00 K-16.03%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly total long term liabilities is $419.00 thousand, with the most recent change of -$80.00 thousand (-16.03%) on September 30, 2024.
- Over the past year, ENLV quarterly long term liabilities has dropped by -$3.40 million (-89.03%).
- ENLV quarterly long term liabilities is now -92.22% below its all-time high of $5.39 million, reached on December 31, 2021.
Performance
ENLV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ENLV Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.6% | -89.0% |
| 3 y3 years | +37.5% | -89.5% |
| 5 y5 years | +246.5% | -89.5% |
ENLV Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.3% | at low | -92.2% | at low |
| 5 y | 5-year | -87.3% | +130.2% | -92.2% | +77.5% |
| alltime | all time | -87.3% | -100.0% | -92.2% | -100.0% |
Enlivex Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $419.00 K(-16.0%) |
| Jun 2024 | - | $499.00 K(-15.0%) |
| Mar 2024 | - | $587.00 K(-14.4%) |
| Dec 2023 | $686.00 K(-83.6%) | $686.00 K(-82.0%) |
| Sep 2023 | - | $3.82 M(+3.1%) |
| Jun 2023 | - | $3.70 M(-7.3%) |
| Mar 2023 | - | $4.00 M(-4.7%) |
| Dec 2022 | $4.19 M(-22.2%) | $4.19 M(-9.0%) |
| Sep 2022 | - | $4.61 M(-0.7%) |
| Jun 2022 | - | $4.64 M(-11.2%) |
| Mar 2022 | - | $5.23 M(-3.0%) |
| Dec 2021 | $5.39 M(+980.0%) | $5.39 M(+0.7%) |
| Sep 2021 | - | $5.35 M(+1221.5%) |
| Jun 2021 | - | $405.00 K(-9.8%) |
| Mar 2021 | - | $449.00 K(-10.0%) |
| Dec 2020 | $499.00 K(+67.4%) | $499.00 K(0.0%) |
| Sep 2020 | - | $499.00 K(+111.4%) |
| Jun 2020 | - | $236.00 K(-7.8%) |
| Mar 2020 | - | $256.00 K(-14.1%) |
| Dec 2019 | $298.00 K | $298.00 K(-66.3%) |
| Sep 2019 | - | $884.00 K(+228.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $269.00 K(-70.0%) |
| Mar 2019 | - | $898.00 K(+353.5%) |
| Dec 2018 | $198.00 K(>+9900.0%) | $198.00 K(>+9900.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(-100.0%) |
| Mar 2016 | - | $125.00 K(+78.6%) |
| Dec 2015 | $70.00 K(>+9900.0%) | $70.00 K(+37.3%) |
| Sep 2015 | - | $51.00 K(+59.4%) |
| Jun 2015 | - | $32.00 K(+146.2%) |
| Mar 2015 | - | $13.00 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00 |
| Dec 2012 | $0.00 | - |
FAQ
- What is Enlivex Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual total long term liabilities year-on-year change?
- What is Enlivex Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly long term liabilities year-on-year change?
What is Enlivex Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ENLV is $686.00 K
What is the all time high annual total long term liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total long term liabilities is $5.39 M
What is Enlivex Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ENLV annual total long term liabilities has changed by -$3.51 M (-83.64%)
What is Enlivex Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ENLV is $419.00 K
What is the all time high quarterly long term liabilities for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total long term liabilities is $5.39 M
What is Enlivex Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ENLV quarterly total long term liabilities has changed by -$3.40 M (-89.03%)